You are here

AusPAR: Alirocumab (rch)

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

2 January 2020
AusPAR Details
AusPAR
Active Ingredient
Alirocumab (rch)
Product Name
Praluent
Sponsor
Sanofi-Aventis Australia Pty Ltd
Submission Number
PM-2018-02973-1-3
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
9 December 2019
Publication Date

2 January 2020